Table 4|.
potential microRNA biomarkers for the diagnosis of AKI
| MictoRNA | Model | Source | Species | Response | Refs |
|---|---|---|---|---|---|
| miR-210, miR-16 and miR-320 | Patients with AKI | Plasma | Human | ↑ (miR-16 and miR-320↓) | 202 |
| miR-21 and miR-155 | Patients with AKI | Urine | Human | ↑ (miR-155↓) | 204 |
| miR-21 | Patients with AKI after cardiac surgery | Plasma and urine | Human | ↑ | 205 |
| miR-494 | Patients with AKI | Urine | Human | ↑ | 174 |
| miR-21, miR-200c, miR-423 and miR-4640 | Patients with AKI | Urine | Human | ↑ (miR-4640↓) | 206 |
| miR-101–1-3p, miR-127–3p, miR-210–3p, miR-126–3p, miR-26b-5p, miR-29a-3p, miR-146a-5p, miR-27a-3p, miR-93–3p and miR-10a-5p | Patients with AKI | Serum | Human | ↓ | 211 |
| miR-10a and miR-30d | Ischaemic AKI | Urine | Mouse | ↑ | 203 |
| miR-10a, miR-192 and miR-194 | Ischaemic AKI | Plasma | Rat | ↑ | 208 |
| miR-714, miR-1188, miR-1897–3p, miR-877 and miR-1224 | Ischaemic AKI | Plasma and kidney | Mouse | ↑ | 210 |
| let-7g-5p, miR-93–5p, miR-191a-5p and miR-192–5p | Cisplatin nephrotoxicity | Urine | Rat | ↑ | 207 |
| miR-200a–c, miR-192 and miR-194 | Contact-freezing-induced AKI | Plasma | Mouse | ↑ | 212 |
AKI, acute kidney injury